![](/img/cover-not-exists.png)
33. Advancing a State of the Art Gene Therapy Called OXB-202 That Resists Corneal Rejection in High Risk Patients
Fouladi, Naghmeh, Binley, Katie, McCloskey, Laura, Loader, Julie, Kelleher, Michelle, Mitrophanous, Kyriacos, Ellis, ScottVolume:
24
Language:
english
Journal:
Molecular Therapy
DOI:
10.1016/s1525-0016(16)32842-8
Date:
May, 2016
File:
PDF, 329 KB
english, 2016